Analisa DiFeo, Ph.D.
Affiliations: | 2008 | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Oncology, GeneticsGoogle:
"Analisa DiFeo"Parents
Sign in to add mentorJohn A. Martignetti | grad student | 2008 | Mount Sinai School of Medicine | |
(The role of KLF6 and KLF6-SV1 in the development and progression of epithelial ovarian cancer: Identification of a novel pro -survival protein that regulates apoptosis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shang S, Yang J, Jazaeri AA, et al. (2019) Chemotherapy-induced distal enhancers drive transcriptional program to maintain the chemoresistant state in ovarian cancer. Cancer Research |
Collins G, Mesiano S, DiFeo A. (2018) Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines. Reproductive Sciences (Thousand Oaks, Calif.). 1933719118779734 |
Belur Nagaraj A, Kovalenko O, Avelar RA, et al. (2018) Mitotic Exit dysfunction through the deregulation of APC/C characterizes cisplatin resistant state in epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
McClinch K, A Avelar R, Callejas D, et al. (2018) Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer. Cancer Research |
Morrow JJ, Bayles I, Funnell APW, et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nature Medicine |
Nagaraj AB, Joseph P, Knarr M, et al. (2018) Abstract B66: miRNA 3’UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity Clinical Cancer Research. 24 |
Hopp E, Joseph P, Nakayama J, et al. (2018) Identifying susceptibilities and pharmacodynamic biomarkers for mirvetuximab soravtansine in high-grade ovarian and endometrial cancer Gynecologic Oncology. 149: 57 |
Collins G, Zolton J, Mesiano S, et al. (2018) The effects of metformin on cellular proliferation and steroid hormone receptor expression in patient derived low grade endometrial cancer cell lines: implications for reproductive sparing treatment using metformin Fertility and Sterility. 109: e21 |
Nagaraj AB, Wang QQ, Joseph P, et al. (2017) Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment. Oncogene |
Saygin C, Wiechert A, Rao VS, et al. (2017) CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. The Journal of Experimental Medicine |